ENTRY       D11843                      Drug
NAME        Cendakimab (USAN/INN);
            Cendakimab (genetical recombination) (JAN)
FORMULA     C6508H10116N1724O2028S44
EXACT_MASS  146276.9156
MOL_WEIGHT  146367.1506
SEQUENCE    (Heavy chain)
            EVTLRESGPG LVKPTQTLTL TCTLYGFSLS TSDMGVDWIR QPPGKGLEWL AHIWWDDVKR
            YNPALKSRLT ISKDTSKNQV VLKLTSVDPV DTATYYCART VSSGYIYYAM DYWGQGTLVT
            VSSASTKGPS VFPLAPSSKS TSGGTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL
            QSSGLYSLSS VVTVPSSSLG TQTYICNVNH KPSNTKVDKK VEPKSCDKTH TCPPCPAPEA
            AGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE
            QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKALPAPIEK TISKAKGQPR EPQVYTLPPS
            REEMTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK
            SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PGK
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ISCRASQDIR NYLNWYQQKP GKAPKLLIFY TSKLHSGVPS
            RFSGSGSGTD YTLTISSLQP EDIATYYCQQ GNTLPLTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H97, H150-H206, H226-L214, H232-H'232, H235-H'235, H267-H327, H373-H431, H'22-H'97, H'150-H'206, H'226-L'214, H'267-H'327, H'373-H'431, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Anti-inflammatory, Anti-IL-13 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of eosinophilic esophagitis
TARGET      IL13 [HSA:3596] [KO:K05435]
DBLINKS     CAS: 2151032-62-9
///
